AAAAAA

   
Results: 1-18 |
Results: 18
Therapeutic potential of the intestinotropic hormone, glucagon-like peptide-2
Authors: L'Heureux, MC Brubaker, PL
Citation: Mc. L'Heureux et Pl. Brubaker, Therapeutic potential of the intestinotropic hormone, glucagon-like peptide-2, ANN MED, 33(4), 2001, pp. 229-235
A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats
Authors: Peters, CT Choi, YH Brubaker, PL Anderson, GH
Citation: Ct. Peters et al., A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats, J NUTR, 131(8), 2001, pp. 2164-2170
Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1
Authors: Rocca, AS LaGreca, J Kalitsky, J Brubaker, PL
Citation: As. Rocca et al., Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1, ENDOCRINOL, 142(3), 2001, pp. 1148-1155
Coregulation of glucagon-like peptide-1 synthesis with proglucagon and prohormone convertase 1 gene expression in enteroendocrine GLUTag cells
Authors: Dhanvantari, S Izzo, A Jansen, E Brubaker, PL
Citation: S. Dhanvantari et al., Coregulation of glucagon-like peptide-1 synthesis with proglucagon and prohormone convertase 1 gene expression in enteroendocrine GLUTag cells, ENDOCRINOL, 142(1), 2001, pp. 37-42
Biological activities of glucagon-like peptide-1 analogues in vitro and invivo
Authors: Xiao, Q Giguere, J Parisien, M Jeng, W St-Pierre, SA Brubaker, PL Wheeler, MB
Citation: Q. Xiao et al., Biological activities of glucagon-like peptide-1 analogues in vitro and invivo, BIOCHEM, 40(9), 2001, pp. 2860-2869
Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease
Authors: Xiao, Q Boushey, RP Cino, M Drucker, DJ Brubaker, PL
Citation: Q. Xiao et al., Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease, AM J P-REG, 278(4), 2000, pp. R1057-R1063
Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats
Authors: Tavares, W Drucker, DJ Brubaker, PL
Citation: W. Tavares et al., Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats, AM J P-ENDO, 278(1), 2000, pp. E134-E139
Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats
Authors: Nie, Y Nakashima, M Brubaker, PL Li, QL Perfetti, R Jansen, E Zambre, Y Pipeleers, D Friedman, TC
Citation: Y. Nie et al., Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats, J CLIN INV, 105(7), 2000, pp. 955-965
Sustained expression of exendin-4 does not perturb glucose homeostasis, beta-cell mass, or food intake in metallothionein-preproexendin transgenic mice
Authors: Baggio, L Adatia, F Bock, T Brubaker, PL Drucker, DJ
Citation: L. Baggio et al., Sustained expression of exendin-4 does not perturb glucose homeostasis, beta-cell mass, or food intake in metallothionein-preproexendin transgenic mice, J BIOL CHEM, 275(44), 2000, pp. 34471-34477
Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine
Authors: Lovshin, J Yusta, B Iliopoulos, I Migirdicyan, A Dableh, L Brubaker, PL Drucker, DJ
Citation: J. Lovshin et al., Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine, ENDOCRINOL, 141(11), 2000, pp. 4194-4201
Oral delivery of glucagon-like peptide-1 in a modified polymer preparationnormalizes basal glycaemia in diabetic db/db mice
Authors: Joseph, JW Kalitsky, J St-Pierre, S Brubaker, PL
Citation: Jw. Joseph et al., Oral delivery of glucagon-like peptide-1 in a modified polymer preparationnormalizes basal glycaemia in diabetic db/db mice, DIABETOLOG, 43(10), 2000, pp. 1319-1328
Structural determinants for activity of glucagon-like peptide-2
Authors: DaCambra, MP Yusta, B Sumner-Smith, M Crivici, A Drucker, DJ Brubaker, PL
Citation: Mp. Dacambra et al., Structural determinants for activity of glucagon-like peptide-2, BIOCHEM, 39(30), 2000, pp. 8888-8894
Human [Gly(2)]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis
Authors: Drucker, DJ Yusta, B Boushey, RP DeForest, L Brubaker, PL
Citation: Dj. Drucker et al., Human [Gly(2)]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis, AM J P-GAST, 39(1), 1999, pp. G79-G91
Biologic properties and therapeutic potential of glucagon-like peptide-2
Authors: Drucker, DJ Boushey, RP Wang, F Hill, ME Brubaker, PL Yusta, B
Citation: Dj. Drucker et al., Biologic properties and therapeutic potential of glucagon-like peptide-2, J PARENT EN, 23(5), 1999, pp. S98-S100
Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans
Authors: Xiao, QA Boushey, RP Drucker, DJ Brubaker, PL
Citation: Qa. Xiao et al., Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans, GASTROENTY, 117(1), 1999, pp. 99-105
Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion
Authors: Rocca, AS Brubaker, PL
Citation: As. Rocca et Pl. Brubaker, Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion, ENDOCRINOL, 140(4), 1999, pp. 1687-1694
Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs
Authors: Sandhu, H Wiesenthal, SR MacDonald, PE McCall, RH Tchipashvili, V Rashid, S Satkunarajah, M Irwin, DM Shi, ZQ Brubaker, PL Wheeler, MB Vranic, M Efendic, S Giacca, A
Citation: H. Sandhu et al., Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs, DIABETES, 48(5), 1999, pp. 1045-1053
Intestinal proglucagon-derived peptides
Authors: Brubaker, PL Drucker, DJ
Citation: Pl. Brubaker et Dj. Drucker, Intestinal proglucagon-derived peptides, CONT ENDOC, 8, 1999, pp. 493-514
Risultati: 1-18 |